Skip to content

Clinical trials

Mesothelioma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20161
20181
20201
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Unknown status3
Active, not recruiting2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Beijing Biotech1
Bristol-Myers Squibb1
Fudan University1
Genmab1
Novartis Pharmaceuticals1
Second Affiliated Hospital of Guangzhou Medical University1
Shenzhen BinDeBio Ltd.1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
Wuhan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma10
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Lung Neoplasms3
Ovarian Neoplasms3
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Melanoma2
Mesothelioma, Malignant2
Pancreatic Neoplasms2

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.